Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Spinal segmental myoclonus as an unusual presentation of multiple sclerosis.
High incidence and increasing prevalence of multiple sclerosis in British Columbia, Canada: findings from over two decades (1991-2010).
Repeated measurement of the attention components of patients with multiple sclerosis using the Attention Network Test-Interaction (ANT-I): Stability, isolability, robustness, and reliability.
Information processing speed and attention in multiple sclerosis: Reconsidering the Attention Network Test (ANT).
Multiple Sclerosis and CCSVI: A Population-Based Case Control Study.
Magnetic Resonance Spectroscopy: A Possible In Vivo Marker of Disease Progression for Multiple Sclerosis?
Acute disseminated encephalomyelitis following infectious mononucleosis in a toddler.
Orientational ordering of carotenoids in myelin membranes resolved by polarized Raman microspectroscopy.
The potential role for ocrelizumab in the treatment of multiple sclerosis: current evidence and future prospects.
Gilenya Safety Update
Modelling Genetic Susceptibility to Multiple Sclerosis with Family Data.
The role of epidemiology in MS research: Past successes, current challenges and future potential.
Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays.
The glial response to intracerebrally delivered therapies for neurodegenerative disorders: is this a critical issue?
Multidisciplinary management of multiple sclerosis symptoms.
Dietary interventions for multiple sclerosis.
The squares test as a measure of hand function in multiple sclerosis.
Contemporary treatment options for relapsing-remitting multiple sclerosis.
Cdk5 regulates developmental remodeling of mushroom body neurons in Drosophila.
Pathophysiology of immune-mediated demyelinating neuropathies - Part II: Neurology.
Effect of comorbidity on mortality in multiple sclerosis.
Automated patient-specific optimization of three-dimensional double-inversion recovery magnetic resonance imaging.
Recent progress in omics-driven analysis of MS to unravel pathological mechanisms.
Estimating time-varying effects for overdispersed recurrent events data with treatment switching.
Acute disseminated encephalomyelitis followed by recurrent or monophasic optic neuritis in pediatric patients.
Pages
« first
‹ previous
…
324
325
326
327
328
329
330
331
332
…
next ›
last »